HomeNewsIndiaGradual fall in recovery rate of COVID-19 patients in Delhi in last 10 days: Data

Gradual fall in recovery rate of COVID-19 patients in Delhi in last 10 days: Data

This is the first time in the past two weeks that the recovery rate has fallen below 40 percent.

June 05, 2020 / 16:31 IST
Story continues below Advertisement
Representative Image (Reuters)
Representative Image (Reuters)

Amid surge in coronavirus cases, recovery rate of COVID-19 patients in the national capital has gradually fallen in the last 10 days, dipping to 39.58 percent as reported on June 4, according to official figures.

This is the first time in the past two weeks that the recovery rate has fallen below 40 percent.

Story continues below Advertisement

Barring June 1, when it saw a spike of 990 cases, Delhi has been recording over 1,000 fresh cases everyday from May 28-June 4, the highest being 1,513 on June 3.

Delhi recorded 1,359 fresh coronavirus cases on Thursday, taking the COVID-19 tally in the city to over 25,000-mark, and the death toll due to the disease mounted to 650, authorities said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show